carbostyril has been researched along with Diabetic Cardiomyopathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, C; Cheng, J; Hao, P; Sui, W; Wang, X; Xing, Y; Xue, F; Zhang, C; Zhang, J; Zhang, M; Zhang, Y | 1 |
Cai, Y; Li, X; Liu, J; Luo, J; Ma, X; Xia, Z; Xie, X; Xu, A; Yan, D; Ying, F | 1 |
2 other study(ies) available for carbostyril and Diabetic Cardiomyopathies
Article | Year |
---|---|
Angiotensin IV attenuates diabetic cardiomyopathy
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Forkhead Box Protein O1; Glucose; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Quinolones; Signal Transduction; Streptozocin; Ventricular Dysfunction, Left | 2021 |
FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
Topics: Animals; Apoptosis; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Disease Models, Animal; Disease Susceptibility; Energy Metabolism; Fatty Acids; Forkhead Box Protein O1; Gene Expression Regulation; Glucose; Glycolysis; Male; Membrane Potential, Mitochondrial; Mitochondria; Myocytes, Cardiac; Oxidation-Reduction; Oxidative Stress; Protein Transport; Quinolones; Rats; Ventricular Function, Left | 2020 |